Hanna Przepiera-Będzak Selected Research

Acquired Hyperostosis Syndrome (SAPHO Syndrome)

1/2021	Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome.
12/2016	Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
8/2016	Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.
1/2015	Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.
1/2013	Serum levels of angiogenic cytokines in psoriatic arthritis and SAPHO syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hanna Przepiera-Będzak Research Topics

Disease

5	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2021 - 01/2013
3	Anterior Uveitis 01/2022 - 01/2016
3	Psoriatic Arthritis 08/2016 - 01/2013
3	Ankylosing Spondylitis 08/2016 - 01/2015
2	Axial Spondyloarthritis 01/2022 - 01/2017
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2016
2	Synovitis 01/2021 - 08/2016
2	Hyperostosis 01/2021 - 08/2016
2	Osteitis 01/2021 - 08/2016
2	Acne Vulgaris 01/2021 - 08/2016
2	Arthritis (Polyarthritis) 01/2017 - 01/2013
2	Thrombosis (Thrombus) 01/2017 - 12/2016
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017 - 01/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Obesity 01/2017
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017
1	Lupus Nephritis 01/2017
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2017
1	Atherosclerotic Plaque (Atheroma) 01/2017
1	Thromboembolism 12/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2016
1	Onycholysis 01/2016

Drug/Important Bio-Agent (IBA)

4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2015
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
3	CytokinesIBA 01/2021 - 01/2013
2	alpha-2-HS-GlycoproteinIBA 01/2022 - 08/2016
2	Antiphospholipid AntibodiesIBA 01/2017 - 12/2016
2	Epidermal Growth Factor (EGF)IBA 03/2016 - 01/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 01/2013
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	amsonic acid (DAS)IBA 01/2017
1	InterleukinsIBA 01/2017
1	AutoantibodiesIBA 01/2017
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	AntibodiesIBA 12/2016
1	enoxaparin sodium FDA LinkGeneric 12/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2016
1	Endothelin-1 (Endothelin 1)IBA 08/2016

Therapy/Procedure

1	Therapeutics 01/2021